Nik Nahad Parto

We are a leading supplier and manufacturer of therapeutic and diagnostic radioisotopes in the field of nuclear medicine, proudly situated within the Cancer Research, Training, and Prevention Institute in Tehran, Iran. Currently, Our primary focus lies in the production of FDG radiopharmaceuticals for cancer therapy. With an unwavering commitment to innovation, we are passionate about pioneering advancements in the future of nuclear medicine. Our principal goal is to remain at the forefront of scientific research and development, encompassing physical, chemical, and pharmaceutical disciplines. We strive to push the boundaries of science, driving progress and excellence in our field.